Jobs / United States / Astrazeneca Pharmaceuticals Lp
Medical Lead - Chronic Lymphocytic Leukemia (CLL)
Astrazeneca Pharmaceuticals Lp · 🇺🇸 US - Gaithersburg - MD
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles15 certified filings for “Associate Director Oncology Outcomes Research” (Medical Scientists, Except Epidemiologists) in MD: $126k–$185k, median $140k. Most were filed at wage level II (47%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Astrazeneca Pharmaceuticals Lp
The US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Astrazeneca Pharmaceuticals Lp →
About the role
Job Title: Medical Lead, Chronic Lymphocytic Leukemia (CLL) Location: Gaithersburg, MD (US) - This is a hybrid role, onsite requirement Welcome to the Oncology Business Unit at AstraZeneca! This is the place to build a world-class career in a dedicated Oncology unit. Here, we are always looking to learn more, welcoming the varied opportunities to expand our horizons or develop niche expertise . Embrace the unparalleled access to industry-leading research, technology, and pipeline product launches with a footprint in every region. Coupled with our agility and sharp focus on talent development, there is an exciting opportunity to accelerate a rewarding and meaningful career. Accountabilities: As Medical Lead, Chronic Lymphocytic Leukemia (CLL), you will help shape and deliver the US Medical Affairs strategy for a priority hematology oncology indication . In this highly visible role, you will lead the Core Medical Team, develop and execute the integrated medical plan, and use scientific, clinical, customer, and multi-channel insights to inform evidence generation, product development, and launch readiness. You will collaborate across Medical, Clinical Development, Patient Safety, Commercial, Market Access, and Field Medical teams to advance science-driven strategies with meaningful impact for patients and the CLL community. Key responsibilities include managing a portfolio of investigator-initiated studies that complement the AstraZeneca clinical development plan, leading the real-world evidence strategy for the assigned indication or asset from concept through execution and communication, and creating the US publication plan for generated evidence. You will also provide medical review and input for key materials, engage strategic external partners, contribute to safety discussions, and support scientific exchange with field medical and key account teams. Essential Skills/Experience: • A Doctorate in Medicine (M.D, D.O), PhD or PharmD degree plus proven experience • A minimum of 5+ years of related work experience in industry, clinical or research institution, preferably in onco-hematology, solid tumors, or related experiences • 1-3 years in HQ Medical Affairs role • Expert technical depth in disease area – Hematology/Oncology • Thorough understanding of drug development and pharmaceutical market support and in-depth knowledge of Hematology/Oncology (clinical evidence and real-world patient management) • Strong leadership with a proven track record of change and impact • Strong business acumen skills and experience with financial management • Proven ability to interact productively with both commercial and scientific/medical colleagues (including Clinical Development teams) , with ability to engage and influence senior stakeholders and work collaboratively in cross-functional teams • Ability to travel nationally and internationally. Travel will be, as appropriate , up to ~30% of the time • Excellent written and oral communication, interpersonal, negotiation and presentation skills Desirable Skills/Experience: • Active license as Doctorate in Medicine (M.D, D.O), PhD or PharmD degree • Additional training such as an M.P.H., M.B.A., or other advanced degree • Product Launch Experience and FDA requirements • Experience working in US market , • Experience in supporting brands or disease area levels in-country, regional, or global organizations is preferred • Experience with the clinical management of leukemia disease , chronic and/or acute • Experience in evidence generation planning and clinical trial design • Experience in a strategy-setting role within Medical Affairs and navigating sophisticated business challenges • Experience in developing